Greenwich Lifesciences Used Its ATM Facility To Issue Shares Directly Into The Market At Prevailing Prices. Proceeds Raised In Q1 2026 Exceeded The Quarter's Cash Burn, Resulting In An Estimated Cash Balance Of About $10.5M As Of March 31